RecruitingEarly Phase 1NCT06749418

Vascular Effects of High-Salt After Preeclampsia

Role of the Mineralocorticoid Receptor in Microvascular Endothelial Dysfunction After Preeclampsia


Sponsor

Anna Stanhewicz, PhD

Enrollment

40 participants

Start Date

Jan 2, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Women who develop preeclampsia during pregnancy are more likely to develop and die of cardiovascular disease later in life, even if they are otherwise healthy. Importantly, women who had preeclampsia have an exaggerated vascular responsiveness to hypertensive stimuli, such as high-salt intake, compared to women who had a healthy pregnancy. The reason why this occurs is unclear but may be related to impaired endothelial function and dysregulation of the angiotensin system that occurs during the preeclamptic pregnancy and persists postpartum, despite the remission of clinical symptoms. While the association between a history of preeclampsia and vascular dysfunction leading to elevated CVD risk is well known, the mechanisms underlying this dysfunction remains unclear. The purpose of this study is to examine the role of vascular mineralocorticoid receptor, the terminal receptor in the angiotensin system that contributes to blood pressure regulation, in mediating exaggerated microvascular endothelial dysfunction before and after a high-salt stimulus. This will help us better understand the mechanisms of microvascular dysfunction these women, and how inhibition of these receptors may improve microvascular function. In this study, we use the blood vessels in the skin as a representative vascular bed for examining mechanisms of microvascular dysfunction in humans. Using a minimally invasive technique (intradermal microdialysis for the local delivery of pharmaceutical agents) we examine the blood vessels in a nickel-sized area of the skin.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This study is examining how a high-salt diet affects blood vessels in women who had preeclampsia (high blood pressure during pregnancy) compared to women who had normal pregnancies. Researchers want to understand whether previous preeclampsia makes blood vessels more sensitive to salt, which could raise future cardiovascular risk. **You may be eligible if...** - You are a woman between 18 and 45 years old - You are between 12 weeks and 5 years postpartum - You either had preeclampsia during your pregnancy OR had a normal pregnancy with no hypertension **You may NOT be eligible if...** - You had high blood pressure or metabolic disease before pregnancy - You had gestational diabetes or gestational hypertension without preeclampsia - You currently smoke - You are taking blood pressure or cholesterol-lowering medications - You are currently pregnant - You have a very low BMI (under 18.5) - You have a known allergy to the study substances Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGEplerenone

Local heating: eplerenone is locally and acutely delivered to the cutaneous microvasculature during local heating of the skin to assess endothelium-dependent dilation, L-NAME is added to assess nitric oxide-dependent dilation during this response.


Locations(1)

University of Iowa

Iowa City, Iowa, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06749418


Related Trials